Delivery Order SPE2DB20D2104-SPE2DB24FU08C

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has a total ceiling value of $47,682.41 and a period of performance through September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has a ceiling value of $41,357.98 and runs through December 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic (0.25-0.5 mg/dose pen, 3 mL) medication. The contract has a ceiling value of $20,946.14 and a period of performance through March 24, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,302.30, is for the supply of Ozempic 0.25-0.5 mg/dose pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract is a firm fixed-price delivery order with a ceiling value of $6,106.29 and a period of performance ending on August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $21,323.21, is for the supply of Ozempic 0.25-0.5 mg/dose pens with a 3 mL volume. The contract has an ultimate completion date of February 24, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has a firm fixed price and a ceiling value of $3,839.52. The ultimate completion date is September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity, with a ceiling value of $8,892.20 and a period of performance through April 1, 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic (0.25-0.5 mg/dose) pens. The contract has a ceiling value of $32,328.69 and an ultimate completion date of June 28, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for Ozempic (0.25-0.5 mg/dose pen, 3 mL) at a firm fixed price of $6,095.58. The award has a ceiling value of $6,095.58 and an ultimate completion date of May 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU08C
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the provision of Ozempic 0.25-0.5 mg/dose pen 3 ml. The contract has a ceiling value of $2,612.34 and a period of performance through May 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:12 PM